{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:10:48Z","timestamp":1778555448139,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,11]]},"DOI":"10.7759\/cureus.108680","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:29:01Z","timestamp":1778552941000},"source":"Crossref","is-referenced-by-count":0,"title":["Nodular Vasculitis Following Aromatase Inhibitor Therapy for Breast Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Samuel","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarine","family":"Tahmazian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javairia","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Jabbour-Aida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","year":"2015","unstructured":"Aromatase inhibitors versus tamoxifen in early breast cancer. patient-level meta-analysis of the randomised trials. Lancet. 2015, 386:1341-52. 10.1016\/S0140-6736(15)61074-1","journal-title":"Lancet"},{"key":"ref2","article-title":"Quality of health care delivered to adults in the United States","volume":"349","author":"Goss JR","year":"2003","unstructured":"Goss JR, Elmore JG, Lessler DS. Quality of health care delivered to adults in the United States. N Engl J Med. 2003, 349:1866-8.","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03803.x","article-title":"Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis","volume":"25","author":"Santoro S","year":"2011","unstructured":"Santoro S, Santini M, Pepe C, Tognetti E, Cortelazzi C, Ficarelli E, De Panfilis G. Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis. J Eur Acad Dermatol Venereol. 2011, 25:596-8. 10.1111\/j.1468-3083.2010.03803.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9518-7","article-title":"Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature","volume":"106","author":"Jhaveri K","year":"2007","unstructured":"Jhaveri K, Halperin P, Shin SJ, Vahdat L. Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature. Breast Cancer Res Treat. 2007, 106:315-8. 10.1007\/s10549-007-9518-7","journal-title":"Breast Cancer Res Treat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105308","article-title":"Aromatase inhibitor-induced inflammatory myopathies: a case series","volume":"89","author":"Bowman S","year":"2022","unstructured":"Bowman S, Lu H. Aromatase inhibitor-induced inflammatory myopathies: a case series. Joint Bone Spine. 2022, 89:105308. 10.1016\/j.jbspin.2021.105308","journal-title":"Joint Bone Spine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.07.030","article-title":"Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients","volume":"59","author":"Segura S","year":"2008","unstructured":"Segura S, Pujol RM, Trindade F, Requena L. Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients. J Am Acad Dermatol. 2008, 59:839-51. 10.1016\/j.jaad.2008.07.030","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.94957","article-title":"Erythema induratum (nodular vasculitis) of the lower extremities without tuberculosis in psoriasis on secukinumab (interleukin 17A inhibition): a case report","volume":"17","author":"Elhaddad M","year":"2025","unstructured":"Elhaddad M, Hassan S, Gant T, Tamashiro C, Carrillo-Kashani A. Erythema induratum (nodular vasculitis) of the lower extremities without tuberculosis in psoriasis on secukinumab (interleukin 17A inhibition): a case report. Cureus. 2025, 17:e94957. 10.7759\/cureus.94957","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114735","article-title":"Panniculitis: part II: mostly lobular panniculitis","volume":"45","author":"Requena L","year":"2001","unstructured":"Requena L, S\u00e1nchez Yus E. Panniculitis: part II: mostly lobular panniculitis. J Am Acad Dermatol. 2001, 45:325-61. 10.1067\/mjd.2001.114735","journal-title":"J Am Acad Dermatol"},{"key":"ref9","article-title":"Drug-induced panniculitides","volume":"149","author":"Borroni G","year":"2014","unstructured":"Borroni G, Torti S, D'Ospina RM, Pezzini C. Drug-induced panniculitides. G Ital Dermatol Venereol. 2014, 149:263-70.","journal-title":"G Ital Dermatol Venereol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.18855","article-title":"Drug-induced granulomatous panniculitis: polarization of M1\/M2 macrophages","volume":"103","author":"Tani N","year":"2023","unstructured":"Tani N, Yamada N, Yoshida Y. Drug-induced granulomatous panniculitis: polarization of M1\/M2 macrophages. Acta Derm Venereol. 2023, 103:adv18855. 10.2340\/actadv.v103.18855","journal-title":"Acta Derm Venereol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub RH","year":"2007","unstructured":"Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007, 28:521-74. 10.1210\/er.2007-0001","journal-title":"Endocr Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471065-nodular-vasculitis-following-aromatase-inhibitor-therapy-for-breast-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:29:03Z","timestamp":1778552943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471065-nodular-vasculitis-following-aromatase-inhibitor-therapy-for-breast-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.108680","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,11]]}}}